1. Home
  2. CNNE vs OABI Comparison

CNNE vs OABI Comparison

Compare CNNE & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNNE

Cannae Holdings Inc.

N/A

Current Price

$17.52

Market Cap

686.6M

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$5.29

Market Cap

742.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNNE
OABI
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
686.6M
742.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
CNNE
OABI
Price
$17.52
$5.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $17.25
$8.33
AVG Volume (30 Days)
445.4K
★ 1.4M
Earning Date
11-09-2026
10-30-2026
Dividend Yield
★ 3.39%
N/A
EPS Growth
N/A
★ 6.56
EPS
★ 0.12
N/A
Revenue
★ $499,700,000.00
$18,666,000.00
Revenue This Year
N/A
$94.10
Revenue Next Year
$0.87
$30.33
P/E Ratio
$147.75
★ N/A
Revenue Growth
★ 3.37
N/A
52 Week Low
$10.46
$1.35
52 Week High
$18.48
$5.43

Technical Indicators

Market Signals
Indicator
CNNE
OABI
Relative Strength Index (RSI) 63.73 60.09
Support Level $15.08 $4.43
Resistance Level N/A $5.30
Average True Range (ATR) 0.49 0.38
MACD 0.09 0.01
Stochastic Oscillator 62.37 85.00

Price Performance

Historical Comparison
CNNE
OABI

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: